About Us
What We Do
Since 2008, Langlands & Associates Consulting Inc. has been a trusted partner to biopharmaceutical companies navigating the complexities of drug development. Our work spans the full development continuum — from early discovery pharmacology and non-clinical research through clinical development, regulatory affairs, drug safety, and expanded access programs. We bring strategic clarity and hands-on expertise to the projects that matter most: getting new medicines to patients.
Why Work With Us
Whether you are a lean startup navigating your first IND, or an established company expanding into new territories, Langlands & Associates brings the depth of experience and the personal attention your program deserves. We'd welcome the opportunity to discuss how we can support your next phase of development.
John Langlands, Ph.D. — Founder & President
John holds a Doctorate from the University of Strathclyde (Glasgow, UK) and brings more than 30 years of experience in the development of new medicines. His expertise spans preclinical and clinical translational research, drug development strategy, regulatory affairs, and early access programs — with a particular focus on connecting innovative therapies to patients with difficult-to-treat conditions and limited options.
Throughout his career, John has held senior leadership roles across the biopharmaceutical industry, including Head of Clinical Operations at DelMar Pharmaceuticals/Kintara Therapeutics, Chief Development Officer at Rakovina Therapeutics, VP of Preclinical Research at Naegis Pharmaceuticals, and Program Director for Pharmaceutical Medicine & Drug Development at UNSW Sydney. He is also co-founder and advisor to MedaSystems Inc.
John is a member of the Society for Neuro-Oncology and the European Society for Medical Oncology, and served as a founding Chair of the Vancouver Pharmaceutical and BioScience Society (PBSS).
Presentations & Thought Leadership
MedaSystems Webinar Series (12 December 2025). Lessons from the Field: A conversation on Expanded Access. https://medasystems.com/webinars
Operationalize Early Access Programmes Europe (16-18 October 2023) London UK. Streamlining collaboration between sponsors and clinicians to improve an Early Access Program.